Scott Noggle, PhD

Scott Noggle, PhD

Senior Vice President, Research at NYSCF

PhD, Medical College of Georgia


Dr. Noggle is a leader in stem cell biology and technology, who oversaw the development of the NYSCF Global Stem Cell Array®, our automated platform for creating stem cells, which allows us to study diseases at the scale of patient populations. He currently leads Alzheimer’s research at NYSCF. He joined NYSCF in 2008.

Dr. Noggle received his PhD from the Medical College of Georgia and completed his postdoctoral research at The Rockefeller University, where he studied stem cells and neurobiology. Before joining the NYSCF Research Institute, he managed Rockefeller University’s Tri-Institutional Stem Cell Initiative’s human embryonic stem cell derivation core facility, where he derived human embryonic stem cell lines on the NIH registry. 

With a longstanding interest in the derivation and use of human stem cells to understand development and disease, Dr. Noggle’s research focuses on creating human models of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, which can be used to identify new therapeutic possibilities. His research uses stem cells as a tool to understand how genetics impact susceptibility to these diseases, to identify disease subtypes with implications for precision medicine, and to define new opportunities for therapeutic intervention. 

Watch a panel discussion and discover how stem cells are helping researchers overcome traditional limitations to Alzheimer’s research.